{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:21:13Z","timestamp":1789172473263,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002744","name":"Bar-Ilan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002744","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Individuals suffering from long-COVID can present with \u201cbrain fog\u201d, which is characterized by a range of cognitive impairments, such as confusion, short-term memory loss, and difficulty concentrating. To date, several potential interventions for brain fog have been considered. Notably, no systematic review has comprehensively discussed the impact of each intervention type on brain fog symptoms. We included studies on adult (aged\u2009&gt;\u200918\u00a0years) individuals with proven long- COVID brain-fog symptoms from PubMed, MEDLINE, Central, Scopus, and Embase. A search limit was set for articles published between 01\/2020 and 31\/12\/2023. We excluded studies lacking an objective assessment of brain fog symptoms and patients with preexisting neurological diseases that affected cognition before COVID-19 infection. This review provided relevant information from 17 studies. The rehabilitation studies utilized diverse approaches, leading to a range of outcomes in terms of the effectiveness of the interventions. Six studies described noninvasive brain stimulation, and all showed improvement in cognitive ability. Three studies described hyperbaric oxygen therapy, all of which showed improvements in cognitive assessment tests and brain perfusion. Two studies showed that the use of Palmitoylethanolamide and Luteolin (PEA-LUT) improved cognitive impairment. Noninvasive brain stimulation and hyperbaric oxygen therapy showed promising results in the treatment of brain fog symptoms caused by long-COVID, with improved perfusion and cortical excitability. Furthermore, both rehabilitation strategies and PEA-LUT administration have been associated with improvements in symptoms of brain fog. Future studies should explore combinations of interventions and include longer follow-up periods to assess the long-term effects of these treatments.<\/jats:p>","DOI":"10.1007\/s10072-024-07566-w","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:02:21Z","timestamp":1714654941000},"page":"2951-2968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Intervention modalities for brain fog caused by long-COVID: systematic review of the literature"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7542-8608","authenticated-orcid":false,"given":"Alon","family":"Gorenshtein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Liba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Leibovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"7566_CR1","doi-asserted-by":"publisher","first-page":"e942244","DOI":"10.12659\/MSM.942244","volume":"29","author":"DV Parums","year":"2023","unstructured":"Parums DV (2023) Editorial: A rapid global increase in COVID-19 is due to the emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2. Med Sci Monit 29:e942244. https:\/\/doi.org\/10.12659\/MSM.942244","journal-title":"Med Sci Monit"},{"key":"7566_CR2","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.ajmo.2023.100033","volume":"9","author":"K Huerne","year":"2023","unstructured":"Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ (2023) Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open 9:100033. https:\/\/doi.org\/10.1016\/j.ajmo.2023.100033","journal-title":"Am J Med Open"},{"issue":"2","key":"7566_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","volume":"9","author":"P Venkatesan","year":"2021","unstructured":"Venkatesan P (2021) NICE guideline on long COVID. Lancet Respir Med 9(2):129. https:\/\/doi.org\/10.1016\/S2213-2600(21)00031-X","journal-title":"Lancet Respir Med"},{"key":"7566_CR4","doi-asserted-by":"publisher","first-page":"n908","DOI":"10.1136\/bmj.n908","volume":"373","author":"E Mahase","year":"2021","unstructured":"Mahase E (2021) Covid-19: One in three has neurological or psychiatric condition diagnosed after covid infection, study finds. BMJ 373:n908. https:\/\/doi.org\/10.1136\/bmj.n908","journal-title":"BMJ"},{"key":"7566_CR5","doi-asserted-by":"publisher","first-page":"120162","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj L, Kannapadi NV, Briggs J et al (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci 434:120162. https:\/\/doi.org\/10.1016\/j.jns.2022.120162","journal-title":"J Neurol Sci"},{"key":"7566_CR6","doi-asserted-by":"publisher","unstructured":"Aghajani Mir M (2023) Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-023-03715-y","DOI":"10.1007\/s12035-023-03715-y"},{"issue":"10","key":"7566_CR7","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1007\/s00415-023-11913-w","volume":"270","author":"GY Lam","year":"2023","unstructured":"Lam GY, Damant RW, Ferrara G et al (2023) Characterizing long-COVID brain fog: a retrospective cohort study. J Neurol 270(10):4640\u20134646. https:\/\/doi.org\/10.1007\/s00415-023-11913-w","journal-title":"J Neurol"},{"key":"7566_CR8","doi-asserted-by":"publisher","first-page":"975992","DOI":"10.3389\/fpubh.2022.975992","volume":"10","author":"D L\u00ed\u0161ka","year":"2022","unstructured":"L\u00ed\u0161ka D, Liptakov\u00e1 E, Babi\u010dov\u00e1 A, Batalik L, Ba\u0148\u00e1rov\u00e1 PS, Dobrodenkov\u00e1 S (2022) What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health 10:975992. https:\/\/doi.org\/10.3389\/fpubh.2022.975992","journal-title":"Front Public Health"},{"key":"7566_CR9","doi-asserted-by":"publisher","first-page":"1150096","DOI":"10.3389\/fneur.2023.1150096","volume":"14","author":"AS Nordvig","year":"2023","unstructured":"Nordvig AS, Rajan M, Lau JD et al (2023) Brain fog in long COVID limits function and health status, independently of hospital severity and preexisting conditions. Front Neurol 14:1150096. https:\/\/doi.org\/10.3389\/fneur.2023.1150096","journal-title":"Front Neurol"},{"issue":"19","key":"7566_CR10","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.3390\/ijerph191912816","volume":"19","author":"Z Chatys-Bogacka","year":"2022","unstructured":"Chatys-Bogacka Z, Mazurkiewicz I, Slowik J et al (2022) Brain fog and quality of life at work in non-hospitalized patients after COVID-19. Int J Environ Res Public Health 19(19):12816. https:\/\/doi.org\/10.3390\/ijerph191912816","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"7566_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s13760-022-02001-3","volume":"123","author":"\u00d6F Bolatt\u00fcrk","year":"2023","unstructured":"Bolatt\u00fcrk \u00d6F, Soylu AC (2023) Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT. Acta Neurol Belg 123(3):1089\u20131093. https:\/\/doi.org\/10.1007\/s13760-022-02001-3","journal-title":"Acta Neurol Belg"},{"key":"7566_CR12","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.bbih.2022.100460","volume":"22","author":"LA Brown","year":"2022","unstructured":"Brown LA, Ballentine E, Zhu Y, McGinley EL, Pezzin L, Abramoff B (2022) The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection. Brain Behav Immun Health 22:100460. https:\/\/doi.org\/10.1016\/j.bbih.2022.100460","journal-title":"Brain Behav Immun Health"},{"key":"7566_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"7566_CR14","doi-asserted-by":"publisher","first-page":"e938732","DOI":"10.12659\/AJCR.938732","volume":"24","author":"CH Chang","year":"2023","unstructured":"Chang CH, Chen SJ, Chen YC, Tsai HC (2023) A 30-year-old woman with an 8-week history of anxiety, depression, insomnia, and mild cognitive impairment following COVID-19 who responded to accelerated bilateral theta-burst transcranial magnetic stimulation over the prefrontal cortex. Am J Case Rep 24:e938732. https:\/\/doi.org\/10.12659\/AJCR.938732","journal-title":"Am J Case Rep"},{"key":"7566_CR15","doi-asserted-by":"publisher","first-page":"111540","DOI":"10.1016\/j.jpsychores.2023.111540","volume":"175","author":"A Kupferschmitt","year":"2023","unstructured":"Kupferschmitt A, J\u00f6bges M, Randerath J, Hinterberger T, Loew TH, K\u00f6llner V (2023) Attention deficits and depressive symptoms improve differentially after rehabilitation of post-COVID condition - A prospective cohort study. J Psychosom Res 175:111540. https:\/\/doi.org\/10.1016\/j.jpsychores.2023.111540","journal-title":"J Psychosom Res"},{"key":"7566_CR16","doi-asserted-by":"publisher","first-page":"20230004","DOI":"10.2490\/prm.20230004","volume":"8","author":"N Sasaki","year":"2023","unstructured":"Sasaki N, Yamatoku M, Tsuchida T, Sato H, Yamaguchi K (2023) Effect of repetitive transcranial magnetic stimulation on long coronavirus disease 2019 with fatigue and cognitive dysfunction. Prog Rehabil Med 8:20230004. https:\/\/doi.org\/10.2490\/prm.20230004","journal-title":"Prog Rehabil Med"},{"issue":"16","key":"7566_CR17","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3390\/cells11162552","volume":"11","author":"P De Luca","year":"2022","unstructured":"De Luca P, Camaioni A, Marra P et al (2022) Effect of ultra-micronized Palmitoylethanolamide and Luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells 11(16):2552. https:\/\/doi.org\/10.3390\/cells11162552","journal-title":"Cells"},{"issue":"1","key":"7566_CR18","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1038\/s41598-023-35058-y","volume":"13","author":"M Samper-Pardo","year":"2023","unstructured":"Samper-Pardo M, Le\u00f3n-Herrera S, Oliv\u00e1n-Bl\u00e1zquez B, M\u00e9ndez-L\u00f3pez F, Dom\u00ednguez-Garc\u00eda M, S\u00e1nchez-Recio R (2023) Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. Sci Rep 13(1):7943. https:\/\/doi.org\/10.1038\/s41598-023-35058-y","journal-title":"Sci Rep"},{"issue":"5","key":"7566_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/brainsci13050791","volume":"13","author":"P Rabaiotti","year":"2023","unstructured":"Rabaiotti P, Cirac\u00ec C, Donelli D et al (2023) Effects of multidisciplinary rehabilitation enhanced with neuropsychological treatment on post-acute SARS-CoV-2 cognitive impairment (Brain Fog): An observational study. Brain Sci 13(5):791. https:\/\/doi.org\/10.3390\/brainsci13050791","journal-title":"Brain Sci"},{"issue":"1","key":"7566_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13256-022-03287-w","volume":"16","author":"AM Bhaiyat","year":"2022","unstructured":"Bhaiyat AM, Sasson E, Wang Z et al (2022) Hyperbaric oxygen treatment for long coronavirus disease-19: a case report. J Med Case Rep. 16(1):80. https:\/\/doi.org\/10.1186\/s13256-022-03287-w","journal-title":"J Med Case Rep."},{"issue":"2","key":"7566_CR21","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.psycr.2023.100164","volume":"2","author":"A Wysoki\u0144ski","year":"2023","unstructured":"Wysoki\u0144ski A, Szczepocka E, Szczakowska A (2023) Improved cognitive performance, increased theta, alpha, beta and decreased delta powers after cognitive rehabilitation augmented with tDCS in a patient with post-COVID-19 cognitive impairment (brain-fog). Psychiatry Res Case Rep 2(2):100164. https:\/\/doi.org\/10.1016\/j.psycr.2023.100164. ISSN 2773-0212","journal-title":"Psychiatry Res Case Rep"},{"issue":"4","key":"7566_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/NRE-230212","volume":"53","author":"LW Braga","year":"2023","unstructured":"Braga LW, Oliveira SB, Moreira AS et al (2023) Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant? NeuroRehabilitation 53(4):517\u2013534. https:\/\/doi.org\/10.3233\/NRE-230212","journal-title":"NeuroRehabilitation"},{"issue":"6","key":"7566_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/RNN-211249","volume":"39","author":"BA Sabel","year":"2021","unstructured":"Sabel BA, Zhou W, Huber F et al (2021) Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restor Neurol Neurosci 39(6):393\u2013408. https:\/\/doi.org\/10.3233\/RNN-211249","journal-title":"Restor Neurol Neurosci"},{"issue":"4","key":"7566_CR24","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3390\/ijerph20043100","volume":"20","author":"JA Du\u00f1abeitia","year":"2023","unstructured":"Du\u00f1abeitia JA, Mera F, Baro \u00d3, Jadad-Garcia T, Jadad AR (2023) Personalized computerized training for cognitive dysfunction after COVID-19: A before-and-after feasibility pilot study. Int J Environ Res Public Health 20(4):3100. https:\/\/doi.org\/10.3390\/ijerph20043100","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"7566_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/ijerph20021361","volume":"20","author":"C Hausswirth","year":"2023","unstructured":"Hausswirth C, Schmit C, Rougier Y, Coste A (2023) Positive Impacts of a four-week neuro-meditation program on cognitive function in post-acute sequelae of COVID-19 patients: A randomized controlled trial. Int J Environ Res Public Health 20(2):1361. https:\/\/doi.org\/10.3390\/ijerph20021361","journal-title":"Int J Environ Res Public Health"},{"key":"7566_CR26","doi-asserted-by":"publisher","first-page":"103438","DOI":"10.1016\/j.ajp.2022.103438","volume":"81","author":"Y Noda","year":"2023","unstructured":"Noda Y, Sato A, Shichi M et al (2023) Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J Psychiatr 81:103438. https:\/\/doi.org\/10.1016\/j.ajp.2022.103438","journal-title":"Asian J Psychiatr"},{"key":"7566_CR27","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1038\/s41598-022-15565-0","volume":"12","author":"S Zilberman-Itskovich","year":"2022","unstructured":"Zilberman-Itskovich S, Catalogna M, Sasson E et al (2022) Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep 12:11252. https:\/\/doi.org\/10.1038\/s41598-022-15565-0","journal-title":"Sci Rep"},{"issue":"8","key":"7566_CR28","doi-asserted-by":"publisher","first-page":"e202200391","DOI":"10.1002\/jbio.202200391","volume":"16","author":"R Bowen","year":"2023","unstructured":"Bowen R, Arany PR (2023) Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog. J Biophotonics 16(8):e202200391. https:\/\/doi.org\/10.1002\/jbio.202200391","journal-title":"J Biophotonics"},{"issue":"6","key":"7566_CR29","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.7861\/clinmed.2021-0462","volume":"21","author":"T Robbins","year":"2021","unstructured":"Robbins T, Gonevski M, Clark C et al (2021) Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond) 21(6):e629\u2013e632. https:\/\/doi.org\/10.7861\/clinmed.2021-0462","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"7566_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/brainsci14030293","volume":"14","author":"V Cenacchi","year":"2024","unstructured":"Cenacchi V, Furlanis G, Menichelli A, Lunardelli A, Pesavento V, Manganotti P (2024) Co-ultraPEALut in subjective cognitive impairment following SARS-CoV-2 infection: An exploratory retrospective study. Brain Sci 14(3):293. https:\/\/doi.org\/10.3390\/brainsci14030293","journal-title":"Brain Sci"},{"issue":"5","key":"7566_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/gps.5076","volume":"34","author":"L Clare","year":"2019","unstructured":"Clare L, Kudlicka A, Oyebode JR et al (2019) Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multicentre randomised controlled trial (the GREAT trial). Int J Geriatr Psychiatry 34(5):709\u2013721. https:\/\/doi.org\/10.1002\/gps.5076","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"7566_CR32","doi-asserted-by":"publisher","first-page":"CD013388","DOI":"10.1002\/14651858.CD013388.pub2","volume":"6","author":"A Kudlicka","year":"2023","unstructured":"Kudlicka A, Martyr A, Bahar-Fuchs A, Sabates J, Woods B, Clare L (2023) Cognitive rehabilitation for people with mild to moderate dementia. Cochrane Database Syst Rev 6(6):CD013388. https:\/\/doi.org\/10.1002\/14651858.CD013388.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"7566_CR33","doi-asserted-by":"publisher","first-page":"205521732110402","DOI":"10.1177\/20552173211040239","volume":"7","author":"KC Munger","year":"2021","unstructured":"Munger KC, Martinez AP, Hyland MH (2021) The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study. Mult Scler J Exp Transl Clin 7(3):20552173211040240. https:\/\/doi.org\/10.1177\/20552173211040239","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"1","key":"7566_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13584-020-00398-x","volume":"9","author":"Y Mizrachi","year":"2020","unstructured":"Mizrachi Y, Shahrabani S, Nachmani M, Hornik A (2020) Obstacles to using online health services among adults age 50 and up and the role of family support in overcoming them. Isr J Health Policy Res 9(1):42. https:\/\/doi.org\/10.1186\/s13584-020-00398-x","journal-title":"Isr J Health Policy Res"},{"key":"7566_CR35","doi-asserted-by":"publisher","first-page":"104529","DOI":"10.1016\/j.msard.2023.104529","volume":"71","author":"IM Nauta","year":"2023","unstructured":"Nauta IM, Bertens D, Fasotti L et al (2023) Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial. Mult Scler Relat Disord 71:104529. https:\/\/doi.org\/10.1016\/j.msard.2023.104529","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"7566_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1176\/appi.ajp.2016.16030360","volume":"174","author":"NT Hill","year":"2017","unstructured":"Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A (2017) Computerized Cognitive training in older adults with mild cognitive impairment or dementia: A systematic review and meta-analysis. Am J Psychiatry 174(4):329\u2013340. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16030360","journal-title":"Am J Psychiatry"},{"issue":"1","key":"7566_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5606\/tftrd.2022.10608","volume":"68","author":"S Kesikburun","year":"2022","unstructured":"Kesikburun S (2022) Non-invasive brain stimulation in rehabilitation. Turk J Phys Med Rehabil 68(1):1\u20138. https:\/\/doi.org\/10.5606\/tftrd.2022.10608","journal-title":"Turk J Phys Med Rehabil"},{"issue":"2","key":"7566_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.psc.2023.02.005","volume":"46","author":"A Boscutti","year":"2023","unstructured":"Boscutti A, De Figueiredo JM, Razouq D, Murphy N, Cho R, Selvaraj S (2023) Noninvasive brain stimulation techniques for treatment-resistant depression: Transcranial Magnetic stimulation and transcranial direct current stimulation. Psychiatr Clin North Am 46(2):307\u2013329. https:\/\/doi.org\/10.1016\/j.psc.2023.02.005","journal-title":"Psychiatr Clin North Am"},{"issue":"3","key":"7566_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/WAD.0000000000000464","volume":"35","author":"T Wang","year":"2021","unstructured":"Wang T, Guo Z, Du Y et al (2021) Effects of noninvasive brain stimulation (NIBS) on cognitive impairment in mild cognitive impairment and alzheimer disease: A meta-analysis. Alzheimer Dis Assoc Disord 35(3):278\u2013288. https:\/\/doi.org\/10.1097\/WAD.0000000000000464","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"7566_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaclp.2022.08.007","volume":"63","author":"A Newhouse","year":"2022","unstructured":"Newhouse A, Kritzer MD, Eryilmaz H et al (2022) Neurocircuitry hypothesis and clinical experience in treating neuropsychiatric symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2. J Acad Consult Liaison Psychiatry 63(6):619\u2013627. https:\/\/doi.org\/10.1016\/j.jaclp.2022.08.007","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"1","key":"7566_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41386-022-01453-8","volume":"48","author":"A Jannati","year":"2023","unstructured":"Jannati A, Oberman LM, Rotenberg A, Pascual-Leone A (2023) Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. Neuropsychopharmacology 48(1):191\u2013208. https:\/\/doi.org\/10.1038\/s41386-022-01453-8","journal-title":"Neuropsychopharmacology"},{"issue":"12 Suppl 2","key":"7566_CR42","doi-asserted-by":"publisher","first-page":"S292","DOI":"10.1016\/j.pmrj.2010.10.013","volume":"2","author":"JT Hashmi","year":"2010","unstructured":"Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR (2010) Role of low-level laser therapy in neurorehabilitation. PM R 2(12 Suppl 2):S292\u2013S305. https:\/\/doi.org\/10.1016\/j.pmrj.2010.10.013","journal-title":"PM R"},{"issue":"Pt 3(Pt 3)","key":"7566_CR43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1469-7793.2000.t01-1-00633.x","volume":"527","author":"MA Nitsche","year":"2000","unstructured":"Nitsche MA, Paulus W (2000) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 527(Pt 3(Pt 3)):633\u2013639. https:\/\/doi.org\/10.1111\/j.1469-7793.2000.t01-1-00633.x","journal-title":"J Physiol"},{"issue":"3","key":"7566_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.neuron.2011.10.008","volume":"72","author":"E Dayan","year":"2011","unstructured":"Dayan E, Cohen LG (2011) Neuroplasticity subserving motor skill learning. Neuron 72(3):443\u2013454. https:\/\/doi.org\/10.1016\/j.neuron.2011.10.008","journal-title":"Neuron"},{"issue":"2","key":"7566_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1179\/016164107X174156","volume":"29","author":"JW Calvert","year":"2007","unstructured":"Calvert JW, Cahill J, Zhang JH (2007) Hyperbaric oxygen and cerebral physiology. Neurol Res 29(2):132\u2013141. https:\/\/doi.org\/10.1179\/016164107X174156","journal-title":"Neurol Res"},{"issue":"5","key":"7566_CR46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/23279095.2022.2041418","volume":"30","author":"AR Alashram","year":"2023","unstructured":"Alashram AR, Padua E, Romagnoli C, Annino G (2023) Hyperbaric oxygen therapy for cognitive impairments in patients with traumatic brain injury: A systematic review. Appl Neuropsychol Adult 30(5):602\u2013613. https:\/\/doi.org\/10.1080\/23279095.2022.2041418","journal-title":"Appl Neuropsychol Adult"},{"issue":"1","key":"7566_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11065-021-09500-9","volume":"32","author":"AB Marcinkowska","year":"2022","unstructured":"Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ (2022) Impact of hyperbaric oxygen therapy on cognitive functions: A systematic review. Neuropsychol Rev 32(1):99\u2013126. https:\/\/doi.org\/10.1007\/s11065-021-09500-9","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"7566_CR48","doi-asserted-by":"publisher","first-page":"e12030","DOI":"10.1002\/trc2.12030","volume":"6","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang F, Zhao L et al (2020) Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer\u2019s disease and amnestic mild cognitive impairment. Alzheimers Dement (N Y) 6(1):e12030. https:\/\/doi.org\/10.1002\/trc2.12030","journal-title":"Alzheimers Dement (N Y)"},{"issue":"10","key":"7566_CR49","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4103\/ija.IJA_613_20","volume":"64","author":"K Senniappan","year":"2020","unstructured":"Senniappan K, Jeyabalan S, Rangappa P, Kanchi M (2020) Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19? Indian J Anaesth 64(10):835\u2013841. https:\/\/doi.org\/10.4103\/ija.IJA_613_20","journal-title":"Indian J Anaesth"},{"key":"7566_CR50","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3389\/fphys.2018.00995","volume":"9","author":"I Pe\u00f1a-Villalobos","year":"2018","unstructured":"Pe\u00f1a-Villalobos I, Casanova-Maldonado I, Lois P et al (2018) Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice. Front Physiol 9:995. https:\/\/doi.org\/10.3389\/fphys.2018.00995","journal-title":"Front Physiol"},{"issue":"4","key":"7566_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3171\/jns.2007.106.4.687","volume":"106","author":"Z Zhou","year":"2007","unstructured":"Zhou Z, Daugherty WP, Sun D et al (2007) Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injury. J Neurosurg 106(4):687\u2013694. https:\/\/doi.org\/10.3171\/jns.2007.106.4.687","journal-title":"J Neurosurg"},{"key":"7566_CR52","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3389\/fpsyg.2018.02495","volume":"9","author":"A Hadanny","year":"2018","unstructured":"Hadanny A, Bechor Y, Catalogna M et al (2018) Hyperbaric oxygen therapy can induce neuroplasticity and significant clinical improvement in patients suffering from fibromyalgia with a history of childhood sexual abuse-randomized controlled trial. Front Psychol 9:2495. https:\/\/doi.org\/10.3389\/fpsyg.2018.02495","journal-title":"Front Psychol"},{"issue":"3","key":"7566_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/14737175.2014.884928","volume":"14","author":"S Efrati","year":"2014","unstructured":"Efrati S, Ben-Jacob E (2014) Reflections on the neurotherapeutic effects of hyperbaric oxygen. Expert Rev Neurother 14(3):233\u2013236. https:\/\/doi.org\/10.1586\/14737175.2014.884928","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"7566_CR54","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/biom11101520","volume":"11","author":"I Gottfried","year":"2021","unstructured":"Gottfried I, Schottlender N, Ashery U (2021) Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomolecules 11(10):1520. https:\/\/doi.org\/10.3390\/biom11101520","journal-title":"Biomolecules"},{"issue":"1\u20133","key":"7566_CR55","first-page":"19","volume":"19","author":"L Raciti","year":"2022","unstructured":"Raciti L, Arcadi FA, Calabr\u00f2 RS (2022) Could palmitoylethanolamide be an effective treatment for long-COVID-19? hypothesis and insights in potential mechanisms of action and clinical applications. Innov Clin Neurosci 19(1\u20133):19\u201325","journal-title":"Innov Clin Neurosci"},{"issue":"6","key":"7566_CR56","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ptr.5601","volume":"30","author":"G Sarnelli","year":"2016","unstructured":"Sarnelli G, Gigli S, Capoccia E et al (2016) Palmitoylethanolamide exerts antiproliferative effect and downregulates VEGF signaling in Caco-2 human colon carcinoma cell line through a selective PPAR-\u03b1-dependent inhibition of Akt\/mTOR pathway. Phytother Res 30(6):963\u2013970. https:\/\/doi.org\/10.1002\/ptr.5601","journal-title":"Phytother Res"},{"issue":"7","key":"7566_CR57","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/npp.2012.25","volume":"37","author":"G D'Agostino","year":"2012","unstructured":"D\u2019Agostino G, Russo R, Avagliano C, Cristiano C, Meli R, Calignano A (2012) Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. Neuropsychopharmacology 37(7):1784\u20131792. https:\/\/doi.org\/10.1038\/npp.2012.25","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"7566_CR58","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/bjp.2008.324","volume":"155","author":"WS Ho","year":"2008","unstructured":"Ho WS, Barrett DA, Randall MD (2008) \u201cEntourage\u201d effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol 155(6):837\u2013846. https:\/\/doi.org\/10.1038\/bjp.2008.324","journal-title":"Br J Pharmacol"},{"issue":"7","key":"7566_CR59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2174\/1871527314666150317224155","volume":"14","author":"M Cipriano","year":"2015","unstructured":"Cipriano M, Esposito G, Negro L et al (2015) Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of \u03b2 amyloid-induced astrogliosis in vitro. CNS Neurol Disord Drug Targets 14(7):828\u2013837. https:\/\/doi.org\/10.2174\/1871527314666150317224155","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"35","key":"7566_CR60","doi-asserted-by":"publisher","first-page":"e2200960119","DOI":"10.1073\/pnas.2200960119","volume":"119","author":"F Crunfli","year":"2022","unstructured":"Crunfli F, Carregari VC, Veras FP et al (2022) Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A 119(35):e2200960119. https:\/\/doi.org\/10.1073\/pnas.2200960119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"7566_CR61","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/biof.1726","volume":"47","author":"TC Theoharides","year":"2021","unstructured":"Theoharides TC, Cholevas C, Polyzoidis K, Politis A (2021) Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. BioFactors 47(2):232\u2013241. https:\/\/doi.org\/10.1002\/biof.1726","journal-title":"BioFactors"},{"issue":"4","key":"7566_CR62","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11481-021-10015-6","volume":"16","author":"E Clough","year":"2021","unstructured":"Clough E, Inigo J, Chandra D et al (2021) Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID [published correction appears in J Neuroimmune Pharmacol. 2021 Dec 11;:]. J Neuroimmune Pharmacol 16(4):770\u2013784. https:\/\/doi.org\/10.1007\/s11481-021-10015-6","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"7566_CR63","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/antiox11050954","volume":"11","author":"M Ercegovac","year":"2022","unstructured":"Ercegovac M, Asanin M, Savic-Radojevic A et al (2022) Antioxidant genetic profile modifies probability of developing neurological sequelae in long-COVID. Antioxidants (Basel) 11(5):954. https:\/\/doi.org\/10.3390\/antiox11050954","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"7566_CR64","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144. https:\/\/doi.org\/10.1038\/s41598-021-95565-8","journal-title":"Sci Rep"},{"issue":"10300","key":"7566_CR65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis I, Fonseca-Rodr\u00edguez O, Farrington P, Lindmark K, Fors Connolly AM (2021) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398(10300):599\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(21)00896-5","journal-title":"Lancet"},{"issue":"1","key":"7566_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40520-021-01912-0","volume":"34","author":"C Rodella","year":"2022","unstructured":"Rodella C, Bernini S, Panzarasa S et al (2022) A double-blind randomized controlled trial combining cognitive training (CoRe) and neurostimulation (tDCS) in the early stages of cognitive impairment. Aging Clin Exp Res 34(1):73\u201383. https:\/\/doi.org\/10.1007\/s40520-021-01912-0","journal-title":"Aging Clin Exp Res"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07566-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07566-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07566-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:07:36Z","timestamp":1718327256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07566-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["7566"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07566-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent from the ethics committee was not required for the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical compliance"}},{"value":"Ethical approval Consent from the ethics committee was not required for the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}